TScan Therapeutics Inc (TCRX)

[FACT-MASTER]

TCRX: S-3 Shelf Registration $300,000,000

https://www.sec.gov/Archives/edgar/data/1783328/000119312524060718/d778597ds3.htm

Excerpt 1

Common Stock and Non-Voting Common Stock

As of March 1, 2024, we had outstanding 43,605,608 shares of voting common stock and 4,276,588 shares of non-voting common stock, held of record by over 70 stockholders (which number does not include beneficial owners whose shares are held by nominees in street name). As of March 1, 2024, we also had outstanding Pre-Funded Warrants to purchase up to 47,010,526 shares of our Voting Common Stock, at a price of $1.9999 per warrant with an exercise price of $0.0001 per share.


Fully diluted is close to 100 million shares outstanding.

Nothing under $10.00 would be fair, imo.

It would be interesting to see who steps up to the plate for the eventual offering, imo.